Please assess the completion status of the following clinical trial:

Trial Title: Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All women above 18 years of age~* Less than 12 weeks of gestation.~* Pregnancy is confirmed by pregnancy test or ultrasound scan.~* missed abortion~* Normal general and gynecological examination.~* The size of the uterus on pelvic examination was compatible with the estimated duration of pregnancy~Exclusion Criteria:~* Hemodynamically unstable.~* Suspected sepsis with temperature 38 °C.~* Concurrent medical illness e.g. hematological, cardiovascular, thromboembolism, respiratory illnesses, recent liver disease or pruritus of pregnancy.~* Presence of intrauterine contraceptive device (IUCD).~* Suspect or proven ectopic pregnancy.~* Failed medical or surgical evacuation before presentation.~* Known allergy to misoprostol.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- sublingual misoprostol (Type: EXPERIMENTAL): Group A (100 patients): will be treated with sublingual misoprostol
- vaginal misoprostol (Type: ACTIVE_COMPARATOR): Group B (100 patients): will be treated with vaginal misoprostol

Based on this trial design, predict the completion outcome and termination type (if applicable).